Pro Medicus Ltd banner

Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 136.16 AUD 1.31% Market Closed
Market Cap: AU$14.2B

EV/IC

45
Current
67%
Cheaper
vs 3-y average of 136.7

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
45
=
Enterprise Value
AU$11.8B
/
Invested Capital
AU$311.3m

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
45
=
Enterprise Value
AU$11.8B
/
Invested Capital
AU$311.3m

Valuation Scenarios

Pro Medicus Ltd is trading below its 3-year average

If EV/IC returns to its 3-Year Average (136.7), the stock would be worth AU$413.9 (204% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-96%
Maximum Upside
+204%
Average Upside
31%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 45 AU$136.16
0%
3-Year Average 136.7 AU$413.9
+204%
5-Year Average 94.3 AU$285.55
+110%
Industry Average 2.4 AU$7.19
-95%
Country Average 1.7 AU$5.19
-96%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close
P/E Multiple
Earnings Growth PEG
AU
Pro Medicus Ltd
ASX:PME
Average P/E: 64.6
60.6
29%
2.1
JP
Medical Data Vision Co Ltd
TSE:3902
227.5
62%
3.7
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
30.9
27%
1.1
JP
M3 Inc
TSE:2413
20.5
16%
1.3
SE
Sectra AB
STO:SECT B
91.5
14%
6.5
US
Doximity Inc
NYSE:DOCS
19.3
15%
1.3
US
W
Waystar Holding Corp
NASDAQ:WAY
35
55%
0.6
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
42.8
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -62.1
69%
N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A

Market Distribution

Higher than 95% of companies in Australia
Percentile
95th
Based on 2 047 companies
95th percentile
45
Low
0 — 1.1
Typical Range
1.1 — 3.5
High
3.5 —
Distribution Statistics
Australia
Min 0
30th Percentile 1.1
Median 1.7
70th Percentile 3.5
Max 3 073.7

Pro Medicus Ltd
Glance View

Pro Medicus Ltd, an Australian company founded in 1983, has etched its name in the field of healthcare IT, primarily through its innovative medical imaging software solutions. The brainchild of Dr. Sam Hupert and Anthony Hall, the company originally sought to provide radiology practices with digital solutions for image management and viewing. Over the years, Pro Medicus has meticulously evolved its offerings to become a leader in picture archiving and communication systems (PACS), radiology information systems (RIS), and an expanding range of e-health solutions. Its flagship product, Visage 7, is renowned for delivering fast and sophisticated viewing capabilities, enabling radiologists to efficiently interpret complex imaging data. Under its hood, the company’s technology is powered by advanced streaming capabilities, allowing for large files to be quickly accessed and reviewed, essential for high-demand environments. The monetization model of Pro Medicus largely revolves around licensing agreements for its software, alongside service and support fees, ensuring a steady and recurring revenue stream. The company has successfully leveraged its expertise to penetrate key markets, notably the United States and Europe, where it partners with some of the most prestigious hospitals and research institutions. By focusing on high-end offerings and fostering long-term client relationships, Pro Medicus has cemented a premium positioning in the healthcare IT landscape. The strategic focus on innovation, coupled with a keen understanding of the evolving needs of healthcare providers, allows Pro Medicus to continually refine its services, ensuring it remains at the forefront of technological advancements that ultimately enhance diagnostic efficiency and patient outcomes.

PME Intrinsic Value
22.19 AUD
Overvaluation 84%
Intrinsic Value
Price AU$136.16
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett